AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parks, E. J.
Right arrow Articles by Schneeman, B. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parks, E. J.
Right arrow Articles by Schneeman, B. O.
Agricola
Right arrow Articles by Parks, E. J.
Right arrow Articles by Schneeman, B. O.

American Journal of Clinical Nutrition, Vol 68, 778-785, Copyright © 1998 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program

EJ Parks, JB German, PA Davis, EN Frankel, CT Kappagoda, JC Rutledge, DA Hyson and BO Schneeman
Department of Nutrition, University of California, Davis 95616, USA.

The goal of this investigation was to determine whether participation in an atherosclerosis treatment program would reduce the oxidative susceptibility of LDL from patients with coronary artery disease. The treatment program included intensive exercise therapy, stress management, and consumption of a diet containing 10% fat. The size and antioxidant and lipid contents of LDL particles from 25 patients were analyzed at baseline and after 3 mo of therapy. The susceptibility of LDL to copper-mediated oxidation was measured by a conjugated diene assay and headspace gas chromatography (HSGC). Atherosclerosis treatment significantly reduced plasma total cholesterol and apolipoprotein B concentrations and the molar ratio of LDL cholesterol ester to apolipoprotein B (P < 0.01). The LDL content of alpha- tocopherol and beta-carotene was increased (27% and 17%, respectively, P < 0.04) and the molar ratio of LDL cholesterol ester the sum of LDL alpha-tocopherol and LDL beta-carotene decreased from 159 at baseline to 122 at 3 mo (P < 0.01). The lag phase of LDL conjugated diene formation increased 24%, whereas the maximum rate of oxidation slowed 29% (P < 0.01). As assessed by HSGC, copper-catalyzed formation of volatile lipid oxidation products was reduced 15% (P < 0.007); the reduction in volatiles was correlated with an increase in the alpha- tocopherol content of LDL (r=-0.48, P < 0.01). The principal determinants of reduced LDL oxidative susceptibility were the particle contents of alpha-tocopherol and beta-carotene. To our knowledge, this is the first report to document a reduction in LDL oxidation in coronary artery disease patients undergoing atherosclerosis-reversal therapy.


This article has been cited by other articles:


Home page
J. Nutr.Home page
E. J. Parks, L. E. Skokan, M. T. Timlin, and C. S. Dingfelder
Dietary Sugars Stimulate Fatty Acid Synthesis in Adults
J. Nutr., June 1, 2008; 138(6): 1039 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. K. Roberts and R. J. Barnard
Effects of exercise and diet on chronic disease
J Appl Physiol, January 1, 2005; 98(1): 3 - 30.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. T Timlin and E. J Parks
Temporal pattern of de novo lipogenesis in the postprandial state in healthy men
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 35 - 42.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. A. Baar, C. S. Dingfelder, L. A. Smith, D. A. Bernlohr, C. Wu, A. J. Lange, and E. J. Parks
Investigation of in vivo fatty acid metabolism in AFABP/aP2-/- mice
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E187 - E193.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Suzuki, Y. Ito, K. Wakai, M. Kawado, S. Hashimoto, H. Toyoshima, M. Kojima, S. Tokudome, N. Hayakawa, Y. Watanabe, et al.
Serum Oxidized Low-Density Lipoprotein Levels and Risk of Colorectal Cancer: A Case-Control Study Nested in the Japan Collaborative Cohort Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1781 - 1787.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Bihan, C. Espinosa, H. Valdes-Socin, S. Salenave, J. Young, S. Levasseur, P. Assayag, A. Beckers, and P. Chanson
Long-Term Outcome of Patients with Acromegaly and Congestive Heart Failure
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5308 - 5313.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. T. Kappagoda, D. A. Hyson, and E. A. Amsterdam
Low-carbohydrate-high-protein diets: Is there a place for them in clinical cardiology?
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 725 - 730.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by The American Society for Nutrition